Related by context. All words. (Click for frequent words.) 74 Chronic lymphocytic leukemia 73 nonmelanoma 72 Acute myeloid leukemia 71 Anaplastic 71 metastatic renal 71 pediatric acute lymphoblastic 70 breast pancreatic 70 histologic subtype 69 malignant neoplasm 69 smoldering myeloma 69 nonsmall cell lung cancer 69 metastatic bladder 68 Renal cell carcinoma 68 Chronic myeloid leukemia 68 skeletal metastases 68 Papillary 68 Myelodysplastic syndrome 68 lung pancreatic 67 Chronic pancreatitis 67 sarcomatoid 67 leukemia lymphomas 67 Basal cell 67 pilocytic astrocytomas 67 AML acute myeloid 67 acute myeloid 67 bladder ovarian 67 Surgical resection 67 ductal adenocarcinoma 67 Soft tissue sarcomas 67 TTR amyloidosis 67 Chronic lymphocytic leukemia CLL 67 hepatocellular carcinomas 67 distinct subtypes 67 oligodendrogliomas 66 neuroendocrine cancers 66 ductal breast cancer 66 Waldenstrom macroglobulinemia 66 cytoreduction 66 Acute myeloid leukemia AML 66 colorectal lung 66 histological subtypes 66 drug Treanda 66 Brain metastases 66 hematological diseases 66 Endometrial cancer 66 seminomas 66 underwent surgical resection 66 carcinoid 66 squamous cell lung cancer 66 deCODE ProstateCancer TM 66 refractory anaplastic astrocytoma 66 Non Hodgkins lymphoma 66 pancreatic adenocarcinoma 65 Glioblastoma multiforme GBM 65 renal cell carcinomas 65 Basal cell carcinoma 65 lymphoproliferative disorders 65 papillary renal cell carcinoma 65 Lewy bodies DLB 65 BRCA deficient 65 Malignant mesothelioma 65 malignant brain 65 lymphocytic leukemia 65 invasive lobular 65 molecular subtypes 65 Squamous cell 65 mycosis fungoides 65 Acute lymphoblastic leukemia 65 deCODE BreastCancer 65 prostate carcinomas 65 carcinoid tumors 65 malignant pleural mesothelioma 65 molecular abnormalities 65 benign neoplasms 65 Myelodysplastic syndromes MDS 65 precursor lesions 65 anaplastic astrocytoma AA 65 Her2 positive 65 metastatic renal cell 65 gastrointestinal stromal tumors GISTs 65 leukaemias 65 Squamous 65 Glioblastoma multiforme 65 pathological hallmark 65 gastrointestinal malignancies 65 malignant cancerous 65 cervical lymph node 65 invasive ductal breast cancer 65 kidney urologic 65 serous ovarian cancer 65 squamous cell carcinoma SCC 65 Synovial sarcoma 65 Myelodysplastic syndromes 65 thetreatment 65 Polycythemia vera 65 bladder cancers 65 LHRH receptor positive 64 pituitary adenomas 64 Chronic myeloid leukemia CML 64 recurrent metastatic 64 intrahepatic bile duct 64 thymoma 64 papillary carcinoma 64 metastatic gastric 64 ErbB2 positive 64 gynecologic malignancy 64 NMIBC 64 nonmelanoma skin cancers 64 essential thrombocythemia ET 64 peritoneal carcinomatosis 64 carcinoma HCC 64 basal cell carcinoma squamous 64 neuroendocrine tumors 64 surgically resectable 64 leukemias lymphomas 64 MGUS 64 genitourinary cancers 64 metastatic medullary thyroid 64 nonproliferative 64 histological subtype 64 muscular dystrophy cystic fibrosis 64 esophageal gastric 64 KRAS oncogene 64 lymphoid malignancies 64 Carcinoid tumors 64 HBeAg negative 64 Hodgkin lymphoma HL 64 osteosarcomas 64 Adjuvant chemotherapy 64 metastatic pancreatic 64 stem cells CSCs 64 bronchogenic carcinoma 64 progressive neurodegenerative 64 thymectomy 64 nonmetastatic 64 essential thrombocythemia 64 seminoma 64 mutated K ras 64 leiomyomas 64 lymphoma multiple myeloma 64 ovarian breast 64 neoplasias 64 basal cell carcinoma BCC 63 idiotype protein 63 urothelial cancer 63 Monoclonal antibody 63 systemic amyloidosis 63 Colon polyps 63 Diabetic nephropathy 63 lung carcinomas 63 colorectal carcinoma 63 urothelial carcinoma 63 intracranial tumors 63 differentiated thyroid 63 renal carcinoma 63 underwent resection 63 adenomatous 63 paraganglioma 63 allogeneic HSCT 63 polycythemia vera essential thrombocythemia 63 supratentorial 63 thyroid carcinoma 63 Relapsing remitting MS 63 Acute myelogenous leukemia 63 hepatorenal syndrome 63 advanced medullary thyroid 63 Adjuvant therapy 63 Hereditary angioedema HAE 63 myeloproliferative diseases 63 recurrent glioblastoma multiforme GBM 63 pancreatic lung 63 Pleural mesothelioma 63 HER2 positive cancers 63 Follicular lymphoma 63 metastatic liver 63 HER2 amplified 63 unresectable tumors 63 HNSCC 63 Hepatocellular Carcinoma HCC 63 progressive neurodegenerative disorder 63 commercialize deforolimus 63 Malignant glioma 63 pheochromocytoma 63 Lung transplantation 63 KRAS mutant 63 RET PTC rearrangements 63 Sentinel node biopsy 63 Wilms tumors 63 Uterine cancer 63 refractory Hodgkin 63 PNET 63 psoriasis Crohn disease 63 stage IIIB IV 63 tumor histology 63 pancreatic ductal 63 carcinoids 63 ovarian prostate 63 T1c 63 chemo resistant 63 Metastatic colorectal cancer 63 Kaposi sarcoma KS 63 lung adenocarcinomas 63 relapsed MM 63 Epithelial ovarian cancer 63 ductal carcinomas 63 malignant pancreatic 63 Meningiomas 63 pulmonary metastases 63 rhabdoid 63 dermatofibrosarcoma protuberans 63 chronic myeloid 63 metastatic colorectal 63 resistant hormone refractory 63 locoregional recurrence 63 hormone receptor negative 63 epithelial tumors 63 hepatocellular carcinoma liver 63 CoC accredited 63 Menopausal hormone therapy 63 gastric carcinoma 63 hematological disorders 63 myelomas 63 Gliomas 63 chemoresistant 63 cervical carcinoma 62 Radical prostatectomy 62 lymphoma subtypes 62 indolent lymphomas 62 histologies 62 pancreatic neuroendocrine 62 mucinous 62 pT2 62 relapsed acute lymphoblastic 62 GISTs 62 Non Hodgkin 62 moderately emetogenic 62 peritoneal cancer 62 RhuDex R 62 CYT# potent vascular disrupting 62 grade serous ovarian 62 ANCA associated 62 Pneumococcal vaccines 62 pancreatic colon 62 RNAi therapeutic targeting 62 medically inoperable 62 transplantation HCT 62 multisystem disease 62 lymphomas leukemias 62 proliferative retinopathy 62 myeloproliferative neoplasms 62 infiltrating ductal carcinoma 62 deCODE AF TM 62 fibroma 62 metastatic lymph nodes 62 Glioma 62 Leukemias 62 alveolar rhabdomyosarcoma 62 thymic carcinoma 62 hamartomas 62 ependymomas 62 breast endometrial 62 juvenile myelomonocytic leukemia 62 neoplastic cells 62 Medulloblastoma 62 hormonally responsive 62 completely resected 62 astrocytomas 62 bile duct cancers 62 urologic diseases 62 Human papillomaviruses 62 haematological cancers 62 cystic fibrosis chronic pancreatitis 62 radiolabeled TM# 62 squamous non 62 monogenic 62 immunodeficiency disorders 62 Roche Herceptin 62 lung esophageal 62 Uveal melanoma 62 Aortic stenosis 62 Epigenomics proprietary 62 PSMA ADC 62 oesophageal adenocarcinoma 62 recurrent NSCLC 62 Familial Adenomatous Polyposis 62 K ras mutations 62 intra arterial chemotherapy 62 Cholangiocarcinoma 62 cisplatin resistant 62 hereditary predisposition 62 GBA mutations 62 cell acute lymphoblastic 62 myeloproliferative disorder 62 Glioblastoma Multiforme GBM 62 colorectal ovarian 62 hormone receptor status 62 multifactorial disease 62 malignant lymphoma 62 biliary tract cancer 62 Sezary syndrome 62 cervical prostate 62 Peritoneal mesothelioma 62 nodal metastasis 62 Vandetanib 62 PRESEPT study 62 castrate resistant 62 medullary thyroid carcinoma 62 autosomal dominant inheritance 62 tuberous sclerosis TS 62 alveolar soft 62 thalassemia sickle cell 62 murine models 62 follicular thyroid cancer 62 Nonalcoholic fatty liver 62 lobular breast cancer 62 liver metastasis 62 CTEPH 62 PCNSL 62 Idiopathic pulmonary fibrosis 62 p# biomarker 62 Lymphocytic 62 prostate adenocarcinoma 62 pancreatic endocrine 62 situ LCIS 62 lobular carcinoma 62 pemphigus vulgaris 62 Inflammatory arthritis 62 neuroendocrine carcinoma 62 myelofibrosis polycythemia vera 62 monoclonal gammopathy 62 FDG PET imaging 62 haematologic 61 multiforme 61 primary hyperparathyroidism 61 basal cell skin 61 epithelioid 61 Screening mammography 61 pilocytic astrocytoma 61 pancreatic prostate 61 Heavy menstrual bleeding 61 Neuroendocrine tumors 61 mutated p# 61 OncoVAX ® 61 HER2 positive breast 61 ovarian colon 61 leukemia AML 61 myeloproliferative neoplasms MPNs 61 elevated LDH 61 breast carcinoma 61 brachytherapy implants 61 metastatic neuroendocrine tumors 61 radiation chemoradiation 61 ADPKD 61 lymphoid tumors 61 Li Fraumeni 61 Estrogen receptor positive 61 esthesioneuroblastoma rare form 61 schwannomas 61 Chronic Myelogenous Leukemia CML 61 Ph + acute lymphoblastic 61 metastatic bone 61 progressively degenerative 61 Ribavirin causes 61 HER2 overexpression 61 node metastases 61 lymphoma Hodgkin lymphoma 61 Prognostic factors 61 embryonal rhabdomyosarcoma 61 operable breast cancer 61 paragangliomas 61 oral squamous cell 61 malignant ascites 61 endometrial breast 61 KRAS mutated 61 renal tumors 61 histologically confirmed 61 missense mutations 61 invasive ductal 61 hematopoietic cancers 61 Myelodysplasia 61 Temsirolimus 61 gastric adenocarcinoma 61 liver transplantations 61 chronic thromboembolic pulmonary 61 Ductal carcinoma 61 medullary thyroid cancer 61 haematologic malignancies 61 cystic fibrosis muscular dystrophy 61 Genetic mutation 61 Adenocarcinoma 61 nonhereditary 61 myopathies 61 gastric cardia 61 neurofibromas 61 benign uterine 61 thyroid cancers 61 proliferative disorders 61 leukemia lymphoma multiple myeloma 61 BRAF mutated 61 hematologic disorders 61 methylation markers 61 Velcade bortezomib 61 ovarian endometrial 61 metastatic lung cancer 61 lymph node enlargement 61 ATG#L# 61 simplex virus 61 biliary cancer 61 visit www.rtanswers.org 61 myelogenous leukemia 61 anaplastic astrocytomas 61 treating sarcoma testicular 61 Opportunistic infections 61 TheraSphere 61 Hurthle cell 61 recurrent glioblastoma multiforme 61 melanoma basal cell 61 coagulation disorders 61 adjuvant cisplatin 61 meningiomas 61 late onset Pompe 61 mesotheliomas 61 chronic hepatitis cirrhosis 61 acute lymphoblastic 61 cirrhosis liver failure 61 Adenomas 61 ZACTIMA 61 invasive ductal carcinoma 61 androgen receptor antagonist 61 Thalomid ® 61 Inflammatory bowel disease 61 faulty BRCA genes 61 atypical hyperplasia 61 Stage IIB 61 cancerous enlargement 61 lymphatic tissue 61 FGFR2 gene 61 Radiofrequency ablation 61 alpha1 antitrypsin deficiency 61 Mammastatin 61 pulmonary metastasis 61 KRAS mutations occur 61 neoplastic 61 squamous histology 61 patientswith 61 cutaneous lupus 61 cervical lymph nodes 61 clinically localized prostate 61 distant metastasis 61 BCG refractory 61 EndoTAGTM 1 61 clinicopathologic 61 myeloproliferative 61 malignant lymphomas 61 FluCAM arm 61 photodynamic treatment 61 papillary thyroid carcinoma 61 immunodeficiencies 61 idiopathic PAH 61 Shark cartilage 61 neoplastic diseases 61 hepatocellular liver 60 autosomal dominant polycystic kidney 60 Intravenous immunoglobulin 60 Oesophageal cancer 60 orchitis 60 Basal Cell 60 chronic lymphocytic 60 Tesmilifene 60 refractory acute lymphoblastic 60 ZACTIMA TM ZD# 60 oncological indications 60 Metastatic breast cancer 60 ovarian lung 60 lupus multiple sclerosis 60 erythema nodosum 60 Pulmonary arterial hypertension 60 Multiple myeloma MM 60 BRCA1 BRCA2 60 CDH1 60 brain metastases originating 60 metaplasia 60 NSCLC tumors 60 pancreatic carcinoma 60 Glioblastomas 60 cisplatin chemotherapy 60 HER2 expression 60 induced anemia 60 acute lymphoid leukemia 60 recurrent ovarian 60 CTL epitopes 60 radioimmunotherapy RIT 60 spontaneous regression 60 PROLARIS 60 Inflammatory breast cancer 60 thalidomide Thalomid 60 diffuse gastric 60 baseline LDH 60 Epstein Barr virus EBV 60 diabetic kidney 60 rheumatologic 60 aerodigestive tract 60 renal hepatic 60 tumors GIST 60 ovarian pancreatic 60 tumor regressions 60 latent celiac disease 60 MGd 60 hormonally sensitive 60 kidney fibrosis 60 surgically resected 60 advanced metastatic prostate 60 autoimmune thyroiditis 60 etiologic agent 60 pediatric neuroblastoma 60 T1a 60 Venous thromboembolism 60 endocrine therapies 60 transthyretin amyloidosis 60 Pneumocystis carinii pneumonia 60 metastatic malignant 60 Benign breast 60 pheochromocytomas 60 thyroid nodules 60 castration resistant hormone refractory 60 hemoglobinopathies 60 candidemia 60 hormone refractory 60 prostate ovarian 60 bacillus Calmette Guerin 60 clinically heterogeneous 60 precancerous condition 60 HER2 neu 60 Pulmonary fibrosis 60 Colorectal cancer CRC 60 testicular germ cell 60 gastrointestinal stromal 60 colorectal adenoma 60 subarachnoid hemorrhage SAH 60 adjuvant systemic 60 Stage IIIb 60 ER CHOP 60 underwent radical prostatectomy 60 prostate carcinoma 60 TTF Therapy 60 SSc 60 appendiceal 60 multi factorial disease 60 untreated metastatic pancreatic 60 iniparib BSI 60 endometrial ovarian 60 Circulating tumor cells 60 Prostatitis 60 rheumatic disorders 60 Renal Cell Carcinoma RCC 60 Interferon beta 60 ductal cancer 60 malignant neoplasms 60 prostate cancer CaP 60 ipsilateral breast 60 Stereotactic radiosurgery 60 pre malignant lesions 60 sCJD 60 rheumatoid arthritis psoriatic arthritis 60 subependymal giant cell 60 total thyroidectomy 60 hepatic metastases 60 YONDELIS 60 MALT lymphoma 60 stage IIIA 60 Dilated cardiomyopathy 60 diagnostic biomarker 60 MYCN amplification 60 TroVax ® 60 common hematologic malignancy 60 Gleevec resistant 60 Oncotype 60 esophagogastric junction 60 pleomorphic 60 pelvic malignancies 60 Chronic sinusitis 60 BrachySil TM 60 Sjögren syndrome 60 primitive neuroectodermal tumor 60 HbF 60 somatic mutations 60 metastatic HER2 positive 60 prognostic indicator 60 Acute Myeloid Leukaemia AML 60 Gorlin syndrome 60 CLL SLL 60 diffuse intrinsic pontine glioma 60 brivanib 60 neuro degenerative disease 60 genitourinary tract 60 lung colorectal 60 Evoltra ® 60 anaplastic 60 pancreatic ovarian 60 osteoblastic 60 lymphoma myeloma 60 Parkinson disease multiple sclerosis 60 hepatic encephalopathy HE 60 germline mutations 60 cervical ovarian 60 Myotonic dystrophy 60 benign prostatic hyperplasia enlarged 60 tumor subtypes 60 intra abdominal abscess 60 SIADH 60 inflammatory demyelinating 60 GPC5 60 ara C 60 colorectal carcinomas 60 neuro degenerative disorders 60 debilitating neurodegenerative 60 HER2 receptor 60 neoplasms 60 gastrointestinal stromal tumor 60 malignant fibrous histiocytoma 60 pharyngeal cancer 60 Human papillomavirus 60 clinically detectable 60 B Cell Lymphoma 60 demyelinating diseases 60 dominantly inherited 60 GIST tumors 60 susceptibility loci 60 Ankylosing spondylitis 60 hypereosinophilic syndrome 60 renal cortical 60 Magnesium deficiency 60 metastatic lesions 60 Polycystic ovary syndrome PCOS 60 gefitinib Iressa 60 lesional 60 GBM tumors 60 nonalcoholic steatohepatitis 60 lymphoproliferative diseases 60 adjuvant radiotherapy 59 antihormonal therapy 59 de aths 59 demonstrated antitumor activity 59 hypervascular tumors 59 oral clodronate 59 medullary thyroid 59 percutaneous drainage 59 EGFR mutation positive 59 leukemia Hodgkin 59 angiosarcoma 59 cytotoxic therapies 59 Juvenile Idiopathic Arthritis JIA 59 Histologically 59 stem cell transplantations 59 PLX STROKE targeting 59 malignant pleural mesothelioma MPM 59 pathological hallmarks 59 refractory gastrointestinal stromal 59 plasmacytoid 59 papillary 59 vaccine GMK 59 Cytomegalovirus CMV 59 Kidney transplantation 59 myeloproliferative disorders 59 commonly mutated genes 59 breast uterine 59 cutaneous melanoma 59 rates Tangka 59 Leukemia lymphoma 59 anastrazole 59 colon pancreatic 59 macroglobulinemia 59 renal cysts 59 Lilly Gemzar 59 neuroblastomas 59 refractory metastatic 59 LungAlert TM 59 lung resections 59 microsatellite instability 59 deCODE BreastCancer TM 59 cerebrovascular disorders 59 debilitating neurodegenerative disorder 59 potent inducer 59 nonalcoholic steatohepatitis NASH 59 abnormal pap smears 59 chromophobe 59 prostate bladder 59 diabetes mellitus DM 59 radiotherapy RT 59 adrenocortical cancer 59 temozolomide TMZ 59 Modrenal 59 anaplastic astrocytoma 59 bladder cervix 59 undergoing radical cystectomy 59 locoregional 59 Amgen Neulasta ® 59 invasive lobular carcinoma 59 colorectal gastric 59 demyelinating 59 localized prostate 59 thiopurine 59 glomerulonephritis 59 HCV infections 59 spinal metastases 59 gastroesophageal junction 59 bone metastasis 59 pancreatic ductal adenocarcinoma 59 undergo radical prostatectomy 59 Pemetrexed 59 urolithiasis 59 hepatocellular cancer 59 hypertension hypercholesterolemia 59 JMML 59 fusion enhancers 59 biochemical abnormalities 59 sJIA 59 carcinoid tumor 59 lobular cancer 59 relapsing remitting MS RRMS 59 cortical dysplasia 59 idiopathic myelofibrosis 59 Genetic variants 59 Glioblastoma Multiforme 59 advanced hepatocellular carcinoma 59 HyperAcute 59 interstitial pneumonitis 59 myelodysplastic syndrome MDS 59 pleural mesothelioma 59 debilitating complication 59 overt nephropathy 59 relapsed mantle 59 neuro developmental disorder 59 genetic lysosomal storage 59 androgen ablation 59 pancreatic NET 59 leukemia APL 59 beta islets 59 neovascularisation 59 haematological 59 non resectable metastatic 59 Pancreatic neuroendocrine tumors 59 induce remission 59 stratifying patients 59 PARP inhibition 59 relapsed leukemia 59 acute leukemias 59 Acute lymphocytic leukemia 59 relapsed ALL 59 gene rearrangements 59 FOLFIRI alone 59 Lymphoid 59 EGFR mutant 59 childhood acute lymphoblastic 59 radiosensitive 59 atypical rhabdoid tumor 59 #F FDG PET 59 fallopian tube carcinoma 59 cutaneous T 59 basal epithelial 59 MYLOTARG 59 anti angiogenic agents 59 glioblastoma multiforme GBM 59 CSF biomarkers 59 follicular Non Hodgkin 59 recurrent bladder 59 aMCI precursor 59 stage IIIb IV 59 chronic rheumatic 59 orthotopic model 59 Pneumococcal pneumonia 59 Inflammatory bowel diseases 59 malignant pheochromocytoma 59 metastatic ovarian cancer 59 colon pancreas 59 IVIG therapy 59 tumor xenograft models 59 Tuberous sclerosis 59 thoracoscopic lobectomy 59 multiple sclerosis Crohn disease 59 renal biopsy 59 neoplasm 59 kinase inhibition 59 MELAS 59 CTAP# Capsules 59 biliary tract cancers 59 surgical debulking 59 medulloblastoma tumors 59 intraepithelial neoplasia 59 mutationally activated 59 radiotherapeutic 59 radiochemotherapy 59 dysplastic lesions 59 osteolytic bone disease 59 activating mutation 59 drug GAP #B# 59 Diabetic neuropathy 59 sinonasal 59 cranial irradiation 59 Endometrial 59 Systemic lupus erythematosus 59 cellular immunotherapy 59 biochemical relapse 59 breast carcinomas 59 MCF7 59 haematological malignancies 59 Mitomycin C 59 adenomatous polyps 59 ovarian malignancy 59 Alessandro Riva 59 pancreatic islet cell 59 neoadjuvant therapy 59 leukemia myeloma 59 immunological diseases 59 unexplained mental retardation 59 gastric cancers 59 Carotid endarterectomy 59 Chronic hepatitis B 59 Canvaxin TM 59 recurrent glioblastoma 59 atypical hemolytic uremic syndrome 59 ductal lobular 59 uterine ovarian 59 HPV subtypes 59 gemcitabine Gemzar ® 59 antiangiogenic therapy 59 benign noncancerous 59 idiopathic pulmonary 59 HGPIN 59 PET CT scanning 59 pathologic diagnosis 59 leiomyosarcoma 59 novel peptide therapeutics 59 mTOR inhibition 59 liver scarring 59 intra abdominal infections 59 lung cancer NSCLC 59 uterine tumors 59 histopathologic findings 59 PNH patients 59 pancreatic bladder 59 refractory chronic lymphocytic 59 clinicopathological 59 hematological malignancy 59 gastrointestinal stromal tumors 59 reduce serum phosphate 59 multimodality therapy 59 Hepatocellular carcinoma 59 aphthous stomatitis 59 precancerous cervical 59 Henoch purpura 59 enterocolitis 59 metastatic adenocarcinoma 59 molecularly defined 59 Bayer HealthCare Onyx Pharmaceuticals 59 Like Waitz Aanesen 59 histologic subtypes 59 osteosarcoma Ewing sarcoma 58 transfusion syndrome 58 Esophageal cancer 58 antimetabolites 58 debulking surgery 58 H. pylori infections 58 circulating endothelial cells 58 rheumatoid arthritis inflammatory bowel 58 ovarian cervical 58 Li Fraumeni syndrome 58 lymphoid organs 58 pT3 58 glioblastoma GBM 58 Gastrointestinal Stromal Tumors 58 cardiac revascularization 58 anti angiogenic therapy 58 Dacogen decitabine 58 acid phosphatase PAP 58 colon esophageal 58 epithelial ovarian 58 humanised antibody 58 immune dysregulation 58 prostate cancer PCa 58 lymphocytic 58 metachronous 58 Mutation Analysis 58 allogeneic bone marrow 58 novel VDA molecule 58 intraperitoneal therapy 58 Non Hodgkin lymphomas 58 Bone marrow transplantation 58 ADAMTS# 58 gemcitabine cisplatin 58 leiomyoma 58 HER2 positivity 58 leukoencephalopathy 58 epilepsy multiple sclerosis 58 Pulmonary hypertension 58 mammographically 58 KRAS status 58 Onko Sure IVD 58 cytogenic 58 lymphoid tissue 58 infantile onset 58 Bayer Nexavar 58 Atopic eczema 58 bladder tumors 58 taxane chemotherapy administered 58 busulfan 58 Huntingtons disease 58 RhuDex ™ 58 myelodysplastic myeloproliferative diseases 58 normal karyotype 58 serum biomarker 58 Malignant tumors 58 endometrioid 58 chronic GVHD 58 DCVax 58 AGHD 58 autoimmune hemolytic anemia 58 debilitating autoimmune 58 tamoxifen Nolvadex ® 58 refractory colorectal cancer 58 gastro intestinal stromal tumors 58 lymphoma leukemia 58 degenerative neurological diseases 58 BRAF V#E 58 ovary uterus 58 Inflammatory diseases 58 post transplant lymphoproliferative 58 epilepsy Parkinson disease 58 Crohns disease 58 eflornithine 58 colorectal prostate 58 Systemic lupus erythematosus SLE 58 mGluR2 NAM 58 PCA3 gene 58 Lupus nephritis 58 colorectal metastases 58 colorectal cancer CRC 58 Novartis Afinitor 58 Cutaneous T 58 epiglottitis 58 cytogenetic abnormalities 58 Genetic predisposition 58 hematopoietic malignancies 58 hPAM4 58 neurological disorder affecting 58 metastatic carcinoma 58 refractory acute myeloid 58 Chlamydia trachomatis infection 58 Sjogren Syndrome 58 prospective multicenter study 58 hereditary pancreatitis 58 HER2 positive metastatic breast 58 Zybrestat 58 advanced adenoma 58 bladder carcinoma 58 multiple sclerosis psoriasis 58 K ras gene 58 immune modulating 58 choriocarcinoma 58 prostate colon 58 OVARIAN 58 gene BRCA2 58 lobular carcinomas 58 IDH mutations 58 JAK mutations 58 including eniluracil ADH 58 investigational immunotherapy 58 lung ovary 58 lymphoproliferative disease 58 Peginterferon alfa 2b 58 gynecological malignancies 58 taxane refractory 58 pretransplant 58 soft tissue sarcomas 58 collagen vascular 58 colorectum 58 benign nodules 58 chromosomal rearrangement 58 bacterial prostatitis 58 lacunar 58 uterine cervix 58 isotypes 58 thrombocytopenic 58 de novo mutations 58 undergone radical prostatectomy 58 Genetic susceptibility 58 lenalidomide dexamethasone 58 parathyroid carcinoma 58 lymphoblastic lymphoma 58 squamous 58 Cloretazine 58 Valvular heart 58 bronchoalveolar lavage BAL 58 Benign Prostatic Hypertrophy 58 underwent radical cystectomy 58 pretreatment serum 58 adenocarcinomas 58 basal cell nevus syndrome 58 polyps growths